The Difference in Carbon Footprint Between Diagnostic Upper GI Endoscopy in Dyspeptic Patients Versus Therapeutic Upper GI Bleeding
THE DIFFERENCE IN CARBON FOOTPRINT BETWEEN DIAGNOSTIC UPPER GI ENDOSCOPY IN DYSPEPTIC PATIENTS VERSUS THERAPEUTIC UPPER GI BLEEDING
1 other identifier
observational
75
1 country
2
Brief Summary
The goal of this observational study is to learn about the carbon footprint produced from diagnostic upper GI endoscopy in patients with dyspepsia and therapeutic upper GI endoscopy in patients with non-variceal upper GI bleeding. The main question it aims to answer is: • How much carbon footprint is generated from upper GI endoscopy Participants are already receiving diagnostic and therapeutic upper GI endoscopy as part of their regular medical care for dyspepsia and non-variceal upper GI bleeding, respectively. The carbon footprint generated from this treatment process is examined.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2025
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2025
CompletedFirst Submitted
Initial submission to the registry
November 21, 2025
CompletedFirst Posted
Study publicly available on registry
December 3, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedDecember 3, 2025
June 1, 2025
3 months
November 21, 2025
November 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To quantify the carbon footprint of diagnostic endoscopy for dyspepsia and therapeutic endoscopy for peptic ulcer bleeding
The primary outcome is to calculate the carbon footprint produced from diagnostic upper GI endoscopy in dyspepsia patients and therapeutic upper GI endoscopy in peptic ulcer patients, focusing on the carbon footprint produced since the patient enter the endoscopy room until they leave the endoscopy room
From enrollment to the time that patients leave the endoscopy room
Secondary Outcomes (3)
To compare carbon emissions between diagnostic and therapeutic upper GI endoscopy
From enrollment to the time that patients leave the endoscopy room
To compare emissions across different hemostatic techniques (clips, argon plasma coagulation, bipolar probe), with or without epinephrine.
From enrollment to the time that patients leave the endoscopy room
To evaluate procedural success rates of bleeding stoppage and adverse events (e.g., perforation, post-procedural sepsis) by different techniques
From enrollment to 30 days after treatment
Study Arms (2)
Diagnostic upper GI endoscopy
Dyspepsia patient receiving diagnostic upper GI endoscopy
Therapeutic upper GI endoscopy
Non-variceal upper GI bleeding patient receiving therapeutic upper GI endoscopy
Eligibility Criteria
Dyspepsia patients and non-variceal upper GI bleeding receiving upper GI endoscopy at King Chulalongkorn Memorial hospital and Sawanpracharak hospital, Thailand
You may qualify if:
- Patients with dyspepsia or non-variceal upper GI bleeding
- Age 20-80 years
- Body mass index of 30 or less;
- Receiving one of the following procedure during upper GI endoscopy:
- For diagnostic endoscopy: Rapid urease test for H. pylori infection For therapeutic endoscopy: stop bleeding with either Argon plasma coagulation or Bipolar hemostasis probe or Hemostasis clip
You may not qualify if:
- Platelet \< 50,000
- INR \> 2.5
- Pregnancy
- History of allergy to IV sedative medication
- Peptic ulcer grade IIc and III according to Forrest classification
- Patient receiving inhalation anesthesia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
King Chulalongkorn Memorial Hospital
Bangkok, 10330, Thailand
Sawanpracharak Hospital
Nakhon Sawan, 60000, Thailand
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof. Dr.
Study Record Dates
First Submitted
November 21, 2025
First Posted
December 3, 2025
Study Start
June 1, 2025
Primary Completion
August 31, 2025
Study Completion
December 31, 2025
Last Updated
December 3, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share